Mercachem B.V.(製薬・医療分野):企業M&A動向

◆英語タイトル:Mercachem B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH205715D
◆発行会社(調査会社):GlobalData
◆発行日:2015年3月25日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:オランダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

Mercachem B.V. (Mercachem) is a contract research company. It provides chemical services to the life science industry. The company offers services in discovery chemistry, medicinal chemistry, and process research. Discovery chemistry services include synthesis of building blocks, scaffolds, metabolites, reference standards, feasibility and validation studies; Mercachem’s process research consists of route scouting, reaction and process optimization, catalyst screening and material supply; and its medicinal chemistry services include design and synthesis of druglike compounds, hit optimization, hit-to-lead and lead optimization. The company has eight synthesis laboratories, a scale up laboratory and analytical facility. Mercachem is headquartered in Nijmegen, Gelderland, and the Netherlands.

Mercachem B.V. – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Mercachem B.V., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Mercachem B.V., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Mercachem B.V., Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
Partnerships 11
Mercachem Enters into Research Agreement with NB Health Lab 11
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 12
Dr. August Wolff GmbH & Co. KG Arzneimittel Enters Into Collaboration With Mercachem 14
DNDi Enters Into Co-Development Agreement With IOTA Pharma, Mercachem, Nycomed, Royal Tropical Institute, University of Bern, VU University And TI Pharma 15
Mercachem B.V. – Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Mercachem B.V., Pharmaceuticals & Healthcare, Key Facts 1
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Mercachem B.V., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Mercachem B.V., Deals By Therapy Area, 2009 to YTD 2015 8
Mercachem B.V., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 10
Mercachem Enters into Research Agreement with NB Health Lab 11
ProQinase Enters Into Co-Development Agreement With Mercachem For Drug Discovery Platform 12
Dr. August Wolff GmbH & Co. KG Arzneimittel Enters Into Collaboration With Mercachem 14
DNDi Enters Into Co-Development Agreement With IOTA Pharma, Mercachem, Nycomed, Royal Tropical Institute, University of Bern, VU University And TI Pharma 15
Mercachem B.V., Key Competitors 17
Mercachem B.V., Key Employees 18

List of Figures
Mercachem B.V., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Mercachem B.V., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Mercachem B.V., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

★調査レポート[Mercachem B.V.(製薬・医療分野):企業M&A動向] (コード:GDPH205715D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Mercachem B.V.(製薬・医療分野):企業M&A動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆